In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma is a Biomarker for Susceptibility to Arginine Depletion.

P.W. Szlosarek, A. Klabatsa, Arben Pallaska, M. Sheaff, P. Smith, T. Crook, M.J. Grimshaw, J.P. Steele, R.M. Rudd, F.R. Balkwill, Dean Fennell

Research output: Contribution to journalArticle

107 Citations (Scopus)
Original languageEnglish
Pages (from-to)7126-7131
Number of pages6
JournalClinical Cancer Research
Volume12(23)
Issue number23
DOIs
Publication statusPublished - 01 Dec 2006

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Szlosarek, P. W., Klabatsa, A., Pallaska, A., Sheaff, M., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P., Rudd, R. M., Balkwill, F. R., & Fennell, D. (2006). In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma is a Biomarker for Susceptibility to Arginine Depletion. Clinical Cancer Research, 12(23)(23), 7126-7131. https://doi.org/10.1158/1078-0432.CCR-06-1101